Critical Partners on FDA's Critical Path

The new C-Path Institute in Tucson, Arizona sits at the heart of FDA's intentions to moderize the drug development process. It has three foundling partners: the Institute (which came out of the existing CERT at the University of Arizona), FDA and SRI. These are the key people in the partnership.